CBD Dosage and THC:CBD Ratio for Pain — A Guide for Ohio Medical Marijuana Patients

One of the most common questions Ohio medical marijuana patients ask after getting their card is a deceptively simple one: how much should I take and what ratio should I choose? These questions don’t have universal answers — but they do have research-informed frameworks that help patients start safely and adjust intelligently. This guide covers what the evidence shows about CBD dosing, THC:CBD ratio selection by pain type, and how to approach product selection at Ohio dispensaries.

This guide applies to all Ohio medical marijuana patients — not just those managing back pain. Whether you are using cannabis for chronic pain, fibromyalgia, MS, PTSD, or another qualifying condition, the dosing and ratio principles covered here are relevant.

Why There Is No Universal Dose or Ratio

Before getting into specific numbers, understanding why no universal dose exists matters. Cannabis dosing varies significantly based on individual body chemistry and endocannabinoid system sensitivity, the specific type and severity of pain being managed, prior cannabis exposure and tolerance, delivery method — oral, inhaled, sublingual, or topical — and the specific product formulation.

A comprehensive living systematic review of cannabis for chronic pain published through PubMed found that high THC to CBD ratio products were associated with small improvements in pain severity versus placebo — but low THC to CBD ratio products showed no significant improvement over placebo in randomized controlled trials. This finding is practically important: it suggests that very CBD-dominant products with minimal THC may not provide meaningful pain relief for many patients — and that some THC is likely necessary for most pain presentations.

What the Research Shows About THC:CBD Ratio and Pain Type

Chronic and Neuropathic Pain — Where the Evidence Is Clearest

For chronic pain — particularly neuropathic pain involving nerve irritation, burning, or shooting sensations — the research most consistently supports products with a meaningful THC component rather than CBD-only formulations.

The AHRQ living systematic review found that comparable THC to CBD ratio products — meaning roughly balanced 1:1 formulations — were associated with small improvements in pain severity, while low THC to CBD ratio products showed no improvement over placebo. For Ohio patients managing neuropathic back pain, MS-related pain, or CRPS, a balanced 1:1 product is typically the most evidence-supported starting point.

Research on nabiximols — a pharmaceutical 1:1 THC:CBD oromucosal spray — has consistently shown meaningful pain reduction for neuropathic conditions across multiple randomized controlled trials, making the 1:1 ratio the most clinically validated option for nerve-related pain.

Inflammatory and Musculoskeletal Pain

For inflammatory pain — including arthritis, fibromyalgia, and conditions where inflammation is the primary driver — CBD’s anti-inflammatory properties become more relevant. Products with a higher CBD content relative to THC — such as 4:1 or 2:1 CBD:THC ratios — may provide meaningful anti-inflammatory effects while minimizing psychoactive effects. However the AHRQ review noted that very low THC products showed no improvement over placebo in controlled trials — suggesting that some THC is still needed for most chronic pain presentations.

Severe and Cancer-Related Pain

For severe pain — including cancer-related pain, post-surgical pain, or conditions where lower-potency products have not provided adequate relief — higher THC content becomes more clinically relevant. Research-based clinical protocols suggest that patients with severe pain and significant prior cannabis experience can start with a balanced CBD:THC product at 2.5 to 5mg of each cannabinoid and titrate more quickly than standard protocols.

Sleep-Disrupted Pain

When pain is significantly disrupting sleep — which is common in fibromyalgia, MS, and chronic back pain — a higher THC ratio in the evening is often more appropriate than a balanced product, given THC’s sedating properties at moderate to higher doses. A product with a 1:2 or higher THC:CBD ratio used specifically in the evening may address both pain and sleep disruption simultaneously.

The Research-Based Starting Protocol for Ohio Patients

The most widely cited clinical dosing framework for medical cannabis in chronic pain — referenced in clinical recommendations published through Physicians Weekly and supported by the clinical cannabis literature — follows three protocols based on patient characteristics:

Standard Protocol — Most Ohio Patients

Start with 5mg of CBD twice daily. Increase by 10mg every two to three days until reaching your symptom goals or a maximum of 40mg per day of CBD. Only add THC if you do not achieve adequate relief with CBD alone.

When adding THC, start with the lowest available dose — typically 2.5mg — and increase slowly. Most clinical guidance recommends not exceeding 30mg of THC per day for most chronic pain patients, with many patients finding adequate relief at much lower doses.

Conservative Protocol — Older Patients, Multiple Medications, Frail Patients

For older Ohio patients — particularly those managing Alzheimer’s disease, Parkinson’s disease, or patients taking multiple medications — a more cautious approach is warranted. Start with 2.5mg of CBD once daily and increase by no more than 2.5mg every three to five days. Add THC only if essential for symptom management, at doses starting at 1.25mg or less.

This conservative approach is particularly important for conditions where THC’s psychoactive and cognitive effects carry additional risk — including Parkinson’s (psychosis risk), TBI (cognitive effects), and older patients generally.

Rapid Protocol — Severe Pain, Cancer, Experienced Users

For patients with severe pain, cancer-related symptoms, or significant prior cannabis experience, a balanced CBD:THC starting dose of 2.5 to 5mg of each cannabinoid once or twice daily is appropriate. Titrate by 2.5 to 5mg of each cannabinoid every two to three days toward symptom goals, with a maximum THC dose of approximately 40mg per day.

Practical Ratio Guide by Pain Condition

Based on the research frameworks above — here is a practical starting point guide by condition for Ohio dispensary product selection:

Chronic back pain (mechanical/structural) — start with a 4:1 or 2:1 CBD:THC oral or sublingual product. Add THC content gradually if CBD-dominant products provide insufficient relief.

Neuropathic pain (burning, shooting, tingling) — 1:1 balanced product is the most evidence-supported starting point. Oral tincture or sublingual delivery for consistent dosing.

Fibromyalgia — 2:1 or 1:1 CBD:THC oral or sublingual product. Evening doses may benefit from higher THC content for sleep support.

PTSD — evidence most consistently supports THC-containing products for intrusion and sleep symptoms. Conservative starting dose given psychosis risk considerations. Discuss specifically with your evaluating physician.

Multiple Sclerosis spasticity — 1:1 balanced product — consistent with nabiximols research evidence. Oral or sublingual delivery.

Cancer-related pain — balanced or higher THC product depending on severity and prior experience. Work with your oncologist and evaluating physician together.

Arthritis — 4:1 or 2:1 CBD:THC for anti-inflammatory effects, with topical CBD products for localized joint pain as a complement.

Glaucoma — discuss with your ophthalmologist before any product selection given the IOP duration considerations specific to this condition.

How to Apply This at Ohio Dispensaries

Ohio’s licensed dispensaries are required to have knowledgeable staff — called dispensary agents — available to assist patients with product selection. When you visit a dispensary with your active Ohio medical marijuana card, you can:

Ask the dispensary agent for products in your target ratio range — for example “I’m looking for a 1:1 or 2:1 CBD:THC oral product.”

Request the certificate of analysis (COA) for any product — this shows the exact cannabinoid content and confirms the labeled ratio is accurate.

Start with the smallest available unit size — for oral products, this typically means the smallest available capsule or tincture serving size rather than the largest.

Keep a simple tracking log as you adjust — noting your dose, timing, ratio, and symptom response over at least two weeks before drawing conclusions about whether a product is working. Our guide on how to track and evaluate your progress when using medical marijuana for back pain in Ohio covers a practical tracking approach that applies to all Ohio MMJ conditions.

What the Research Does Not Yet Answer

Being honest about the limits of current dosing research matters for Ohio patients setting expectations.

There are no large-scale, long-term randomized controlled trials that have definitively established optimal dosing protocols for specific chronic pain conditions. Most clinical guidance is based on expert consensus, smaller trials, and observational data rather than definitive controlled evidence. Individual responses vary significantly — the protocols above are starting frameworks, not prescriptions.

The most consistent finding across all dosing research is that starting low and increasing gradually — giving at least two weeks at each dose level before adjusting — produces better outcomes and fewer adverse effects than starting with higher doses. Patience in the titration process is not optional — it is the most evidence-supported aspect of cannabis dosing for pain.

If you are an Ohio patient who has obtained your medical marijuana card and is ready to begin the process of finding the right dose and ratio for your condition, you can schedule your evaluation with an Ohio-certified provider here.

Frequently Asked Questions

Sources

• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain — PubMed / AHRQ
• Recommendations for Dosing and Administering Medical Cannabis for Chronic Pain — Physicians Weekly
• Ohio Medical Marijuana Control Program — Ohio Division of Cannabis Control
• State Medical Board of Ohio — Medical Marijuana Program — med.ohio.gov